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iNtroductioN
The most common illicit drug used by 
women of reproductive age and by pregnant 
women is cannabis (DrugInfo, 2005). 
Although there are limited national data 
available on illicit substance use among 
parents in Australia, the 2007 National 
Drug Strategy Household Survey estimated 
12% of parents with children aged 0–14 
years used either an illicit substance 
(such as marijuana or ecstasy) or a licit 
substance (such as painkillers) for non-
medical purposes in the previous 12 months 
(Australian Institute of Health and Welfare 
[AIHW], 2009). 
“Maternal substance abuse is a potent risk 
condition” (Boris in Zeanah, 2000) as infant 
development can be affected by interrelated 
mechanisms that are all clinically important; 
These can be:
• direct prenatal effects
•  genetic effects (that influence both 
parent and infant)
• cumulative social risks. 
For maternal child and family health nurses, 
identification and early intervention through 
active engagement is a priority. It is also 
essential to have knowledge of alcohol and 
drug use, its impact on the user and the 
baby, and what this means for the parents’ 
capacity to care for their infant. This article 
will address these issues and provide an 
update about cannabis use.
oVerView of pareNtal drug 
uSe – iSSueS for practice 
There are significant challenges in caring for 
families where parental substance abuse has 
an impact on their capacity to care for their 
baby. When assessing the family situation 
and the needs of the child, the maternal 
child and family health nurse needs to 
consider: 
•  the direct effects of the drug use on the 
developing fetus 
•  the likelihood that parents with drug and 
alcohol problems have particular traits 
that influence parenting behaviour
•  the fact that parental substance abuse 
is often linked to other risk factors that 
impact on the baby’s social environment 
(Boris in Zeanah, 2000). 
When considering these factors, it is 
essential to remember that the baby and its 
family must be supported antenatally – via 
family, friends and services – through the 
early years of life in order for the child to 
achieve optimal growth and development in 
the best possible environment. 
Healthy child development
A healthy pregnancy is essential for healthy 
fetal development. ‘Prenatal maternal 
nutrition, exposures and behaviours are 
controllable factors that may impact both 
the fetal brain development and later 
neurodevelopmental outcomes’ (Massaro, 
Rothbaum, 2006). As with other areas of 
uSe of caNNabiS iN pregNaNcy aNd aS a New pareNt
    
        
         
       
          
         
       
          
          
         
   
         
           
           
        
         
  
         
       
  
        
         
    
          
        
     
         
     
         
         
 
          
      
         
      
         
       
      
           
        
         
     
     
 
       
       
          
        
       
       
       
        
    
       
        
       
    
       
         
       
        
       
        
          
      
     
        
       
    
         
          
         
         
        
          
  
  
   
 
      
  
  
     
  
  
      
    
    
     
 
      
   
    
  
     
  
      
  
    
     
 
      
     
      
   
      
     
  
      
  
 
    
     
 
      
     
        
       
     
        
        
        
     
      
 
    
       
 
     
       
   
         
      
        
  
       
     
    
   
       
     
      
     
 
        
      
      
  
      
      
       
     
     
       
     
   
       
       
      
        
       
       
    
     
        
     
   
COMMUNITY PAEDIATRIC REVIEW 2       
         
           
        
      
    
    
    
      
    
       
          
      
        
   
        
         
         
         
         
        
         
   
        
        
       
         
      
        
         
         
           
         
        
 
       
            
       
         
        
     
   
    
    
  
   
    
   
    
   
   
        
         
         
          
         
       
        
          
          
   
          
       
          
         
         
          
           
      
        
       
        
        
      
   
 
    
 
 
   
            
 
      
         
     
       
        
      
        
     
   
        
        
         
       
        
       
          
        
        
        
         
      
        
        
         
       
        
         
         
      
          
         
      
       
         
          
       
       
        
       
        
        
 
   
       
         
        
        
           
         
       
        
       
        
          
        
   
         
          
           
    
         
       
  
         
      
 
        
       
      
  
           
      
         
        
   
         
   
fetal growth, the development of the brain is reliant 
on the availability of adequate oxygen, protein, energy 
and micronutrients to support the complex metabolic 
processes (Massaro et al., 2006). 
Research has highlighted the importance of early 
experiences and their affect on physical health, cognitive 
development, emotional regulation (including the stress 
response system) and mental health across the life 
course (Jordan & Sketchley, 2009). This in turn affects 
the baby’s capacity to function well as an adult. The key 
component of the baby’s environment is the presence 
of caring adults or attachment figures who provide the 
baby with nurturing and responsive relationships based 
on trust and a sense of safety – a secure relationship. 
Considering this knowledge, the consequences of 
maternal drug use during pregnancy and following the 
birth have serious implications for the long-term health 
and wellbeing of the baby. 
factS about caNNabiS 
The psychoactive chemical in cannabis that makes users 
feel ‘high’ is called THC (delta-9 tetrahydrocannabinol). 
THC is absorbed quickly into the blood and is a 
‘depressant’ drug that slows down the activity of the 
central nervous system, including the brain. It can 
also cause mild hallucinogenic effects which may be 
apparent within a few minutes and can last up to five 
hours. THC is absorbed quickly into body fat and is then 
released very slowly back into the blood. It can take up 
to one month for a single dose of THC to fully leave the 
body.
cannabis use – the financial and social costs
Cannabis use is associated with a number of negative 
effects including the financial cost and the substantial 
risk of cannabis dependence. Cannabis use is also 
associated with an increased probability of other illicit 
drug use, engagement in criminal activity, and poor 
educational attainment and employment prospects 
(McLaren, Lemon, Robins & Mattick, 2008).
types of cannabis 
There is a variety of forms of cannabis: 
•	 	Marijuana – is the most common and least powerful 
form of cannabis. It is made from dried plant leaves 
and flowers. The flower (or ‘head’), is the most 
potent form of the plant. Marijuana resembles 
chopped grass and ranges in colour from grey-
green to greenish-brown. It is usually smoked in a 
waterpipe (bong), a pipe or in a hand-rolled cigarette 
(joint). Other names for marijuana include grass, 
weed, cannabis, mull, pot, dope and yarndi. 
•	 	Hashish – consists of small blocks of light brown to 
almost black cannabis resin. The concentration of 
THC in hashish is higher than in marijuana. 
•	 	Hash	oil – is a thick, oily liquid extracted from 
hashish and ranges in colour from golden-brown 
to black. It is usually spread on the tip or paper 
of cigarettes and then smoked. Hash oil is more 
powerful than these other forms of cannabis.
In Australia, marijuana is far more common than hashish 
or hash oil. Cannabis smoke has more tar and contains 
a higher concentration of certain cancer-causing 
(carcinogenic) agents than the smoke from tobacco.
what you may observe in a cannabis user
Cannabis use affects each individual differently. A 
person using cannabis may appear to be very relaxed, 
or have trouble concentrating. Others may be more 
talkative or appear drowsy with reddened eyes. They 
may also present as poorly coordinated or clumsy. 
A user of larger amounts or stronger forms of cannabis 
may find these effects are exacerbated and may present 
as nauseated, confused, restless, anxious, panicky or 
overly excited. Some users may report hallucinations or 
exhibit symptoms of paranoia.
Long-term cannabis users may experience additional 
effects which include poor concentration, memory loss 
and learning difficulties. They may also suffer from 
repeated infections due to a depressed immune system.
cannabis use and associated mental health 
problems
The findings of the National Drug Strategy report, 
Cannabis and Mental Health: put into context (2008) 
addressed the complexity of the relationship between 
cannabis use and the development of mental health 
problems. The report found:
•  The evidence that cannabis use causes psychotic 
disorders is not conclusive; however there is good 
evidence that cannabis use can contribute to the 
development of psychosis in predisposed people and 
can exacerbate existing psychotic disorders.
•  There is some evidence that cannabis use is 
associated with an increased risk of depression, 
particularly with long-term, frequent use and early 
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initiation of use. These risks may be greater for 
females.
•  The younger the person is when they begin to 
use cannabis, the more likely are other adverse 
outcomes associated with cannabis, such as 
dependence, financial cost/hardship, poorer 
educational achievement and employment 
prospects (McLaren et al., 2008).
tHe effect of pareNtal caNNabiS uSe 
oN tHe uNborN cHild 
Cannabis use during pregnancy is potentially harmful. 
THC crosses the placenta easily and this may result in 
shortened gestation, decreased fetal growth, decreased 
infant birth weight and length, and meconium staining 
(Hockenberry & Wilson, 2009).
Regular cannabis use during pregnancy may also serve 
to increase the effects of other drugs and alcohol 
on the developing baby. Since cannabis use is often 
combined with tobacco use, there is increased risk to 
the developing baby due to the combination of the 
effects of tobacco smoke, nicotine and THC. Smoking 
marijuana reduces the amount of oxygen in fetal blood 
similar to smoking tobacco.
the effect of parental drug use on the infant
Infants of mothers who use drugs (including cannabis) 
and/or alcohol during their pregnancy may experience 
a withdrawal process in the days following birth. This 
condition is called Neonatal Abstinence Syndrome 
(NAS). Most infants appear normal at birth, however 
the infant of a drug and/or alcohol using mother 
may begin to exhibit signs of withdrawal within the 
first 24 hours of life. The amount and type of drug, 
the frequency of drug use and the complication of 
multidrug use all influence the initial presentation of 
NAS. 
The signs of withdrawal become more pronounced 
in the 48 - 72 hours after birth and the infant may 
continue to experience the manifestations of NAS 
for up to two months, depending on the severity 
of withdrawal. Signs of withdrawal in the neonate 
include:
• irritability, unsettled behaviour, sleep problems
• tremors, jitteriness, seizures
• excessive crying; high-pitched cry
• sneezing, yawning, nasal stuffiness
• poor feeding
• vomiting, diarrhoea 
• frantic sucking of hands
• hypertonicity of muscles
• fever, temperature instability, perspiring
(Hockenberry & Wilson, 2007).
care of tHe iNfaNt
Discharge of mothers and their infants from maternity 
units within 24 hours of birth is common practice. 
In some cases mothers may not have disclosed their 
drug use at their antenatal visits and in other cases 
there may have been poor attendance by the pregnant 
woman to antenatal appointments. In these situations, 
the maternal child and family health nurse providing 
the first home visit may be presented with a baby 
displaying the early signs of NAS and may require a 
complex care plan. 
The nurse will need to assess the complexity of the 
situation, taking into consideration the mother’s past 
and current drug use and the family dynamics, as well 
as the availability (or lack of) community links and 
supports. If the mother is able to provide appropriate, 
safe care for her infant, the maternal child and family 
health nurse will need to work with the mother to put 
in place strategies to address NAS. 
Strategies to address an infant’s NAS, as recommended 
in The ‘National Clinical Guidelines for the 
Management of Drug Use during Pregnancy, Birth and 
the Early Development Years of the Newborn’ 2006 
(The guidelines) suggest supportive care interventions, 
including:
• a quiet setting
• breastfeeding
    
 
 
   
            
 
      
         
     
       
        
      
        
     
   
        
        
         
       
        
       
          
        
        
        
         
      
        
        
         
       
        
         
         
      
          
         
      
       
         
          
       
       
        
       
        
        
 
   
       
         
        
        
           
         
       
        
       
        
          
        
   
         
          
           
    
         
       
  
         
      
 
        
       
      
  
           
      
         
        
   
         
   
         
        
       
     
       
        
      
        
         
           
        
         
       
           
      
        
        
     
   
        
       
          
         
        
        
           
           
           
             
       
         
        
        
        
        
     
     
   
        
	 	          
          
         
       
       
         
         
       
       
	 	           
       
        
	 	 	          
       
           
         
      
         
          
      
      
       
       
         
        
        
        
          
         
       
        
   
      
       
        
       
      
        
        
       
        
   
         
        
        
       
    
          
       
       
‘NAS is a syndrome of drug withdrawal observed in 
infants of mothers physically dependent on drugs, 
manifested by nonspecific symptoms and signs in 
the infant. NAS is more common in infants born 
to opioid-dependent women than in infants born 
to women dependent on other drugs or alcohol’ 
National Clinical Guidelines for the Management 
of Drug Use during Pregnancy, Birth and the Early 
Development Years of the Newborn 2006
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• use of a ‘dummy’
• cuddling
• swaddling
• small frequent feeds
•  close skin contact by carrying in a sling and other 
methods. 
The guidelines also recommend close monitoring 
of the baby’s weight loss during the period of 
withdrawal because feeding disturbances are 
common. If caloric intake appears insufficient with 
breastfeeding alone, the child and family nurse may 
need to consider recommending expressed breast 
milk or formula to supplement the baby’s feeding 
until adequate caloric intake is established.
breastfeeding and cannabis use
The active component of cannabis, THC, is fat 
soluble and is rapidly distributed into brain and 
adipose (fatty) tissue. The analysis of breast milk in 
chronic heavy cannabis users shows an eightfold 
accumulation of THC in breast milk compared to 
plasma. Infants exposed to cannabis through breast 
milk will test positive in urine screens for two to 
three weeks (Liston, 1998). These infants may often 
exhibit signs of sedation, weakness and poor feeding 
patterns. Cannabis has also been implicated in the 
reduction of basal prolactin levels which may lead to 
decreased milk production (Hockenberry & Wilson, 
2007).
As suggested by Hockenberry & Wilson (2007), the 
potential risks of a cannabis user breastfeeding her 
infant should be weighed up against the benefits of 
breastfeeding. Since cannabis is a long-acting drug, 
it is not recommended to advise a breastfeeding 
mother to take the drug after breastfeeding (as for 
alcohol). As women who use cannabis often do so 
by smoking marijuana, the guidelines recommend 
that advice to mothers and others should be as for 
tobacco: smoke away from the infant, out of the 
house, and not in the car. 
Breastfeeding mothers should also be informed that 
their milk production may be reduced by as much 
as 250mls per day if they choose to smoke tobacco. 
As tobacco is sometimes mixed with marijuana 
for smoking this is relevant to cannabis-using 
mothers. If the mother continues to use cannabis 
while breastfeeding, her baby will require regular 
monitoring of growth and development by both a 
paediatrician and a maternal child and family health 
nurse. 
approacHeS to care 
Ongoing work with mothers where cannabis use 
is evident presents a number of challenges for the 
maternal child and family health nurse. Initial work 
may focus on the development of the relationship 
with the mother in an effort to support her to safely 
care for her baby. The development of a partnership 
through successful engagement of the mother is 
crucial to the relationship. The 2006 National Clinical 
Guidelines stress the importance of the practitioner’s 
engagement skills. Some of the skills listed include 
possessing:
1.  an understanding of one’s own values and beliefs 
in a way that results in non-judgemental attitudes 
to people in care
2.  an understanding of addiction as a healthcare 
issue and not an issue for moral, social or other 
judgments
3.  the ability to create an environment that is safe 
and ensures privacy and confidentiality
4.  an understanding that disclosing drug and alcohol 
use is difficult and acknowledging the woman’s 
feelings and perceptions
5.  an understanding of potential barriers to the 
woman accepting care, and strategies for 
overcoming them
6.  an understanding of the significance of 
establishing and sustaining a sound and trusting 
professional relationship with women with drug 
and alcohol issues
7.  an awareness that drug and alcohol use is not 
isolated from other psychosocial and cultural 
factors
8.  awareness that women with drug and alcohol 
issues often have a number of service providers 
involved in their lives.
9.  a commitment to providing optimal and timely 
healthcare for every individual
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SHort aNd loNg-term care iSSueS
There are short and long-term health and wellbeing 
issues for the infant and the mother associated with 
cannabis use. Cannabis use causes reality distortion 
and this may create a situation where a mother may 
find it hard to cope with an emergency situation 
or have difficulty performing small motor activities. 
The mother may also have a desire for sleep after 
the ‘high’ wears off. Sometimes this is a deep heavy 
sleep, in which the mother may be unresponsive to 
her baby’s needs. 
The maternal child and family health nurse will need 
to work with the mother to ensure the level of risk 
is reduced for the baby as well as for the mother. 
By using a ‘harm minimisation’ approach, the nurse 
informs the mother of the risks and addresses issues 
such as: 
•  Sudden Infant Death Syndrome (SIDS) – discuss 
the risks and provide information about safe 
sleeping and co-sleeping
•  passive smoking – provide information about 
the dangers of the baby being exposed to both 
cannabis (marijuana) and tobacco smoke
•  the baby’s growth and development – talk with 
the mother about the importance of the baby’s 
and her own nutritional needs 
•  the importance of the mother/baby relationship – 
discuss the baby’s need for nurturing
•  breastfeeding – highlight the risks of exposure 
to THC to the baby (through breast milk and 
marijuana smoke)
•  referral to drug and alcohol services – encourage 
seeking help to address the drug use
•  mental health concerns – highlight the association 
of mental health disease and cannabis use
•  confidentiality and child protection concerns – if 
the situation supports an open and transparent 
nurse/mother partnership, be explicit in addressing 
the risk to the child. If this is not possible, the 
nurse needs to consider the risk and protective 
factors for the child and subsequently act in the 
best interests of the child. 
wHeN iS a cHild protectioN 
NotificatioN NeceSSary?
All state and territory jurisdictions have specific 
legislation with regard to child protection. Although 
drug and alcohol use alone may not be an indicator 
for a child protection report or notification, child 
protection is a consideration when working with 
families where parental drug use is present. 
Legislation requires that the safety and wellbeing 
of the child is a paramount consideration (NSW 
Department of Health, 2006). 
There is substantial evidence that the co-occurrence 
of parental substance misuse and other mental health 
disorders is associated with a significantly heightened 
risk of child maltreatment. 
Children living with parents who are problematic 
alcohol or substance users are at greater risk of 
poor health and wellbeing outcomes. The impact 
of parental substance use on children may differ 
between families depending on risk and protective 
factors. However, children are at greater risk when 
exposed over a long period of time to multiple risk 
factors including parental mental health problems, 
socioeconomic disadvantage, crime and violence 
(Dawe et al. 2007). Parents who are problematic 
alcohol or substance users often have co-existing 
mental health problems (AIHW, 2009).
coNcluSioN
As part of the ongoing care with families where 
parental drug use is an issue, the maternal child and 
family health nurse will need to continually assess the 
risk and protective factors for the child. Although this 
can sometimes be very challenging, it is absolutely 
critical to always continue to act in the best interests 
of the child.
  
   
 
      
  
  
     
  
  
      
    
    
     
 
      
   
    
  
     
  
      
  
    
     
 
      
     
      
   
      
     
  
      
  
 
    
     
 
      
     
        
       
     
        
        
        
     
      
 
    
       
 
     
       
   
         
      
        
  
       
     
    
   
       
     
      
     
 
        
      
      
  
      
      
       
     
     
       
     
what is harm minimisation?
It is the primary principle underpinning the 
National Drug Strategy and refers to policies 
and programs aimed at reducing drug-related 
harm. It aims to improve health, social and 
economic outcomes for both the community and 
the individual, and encompasses a wide range 
of approaches, including abstinence-oriented 
strategies. Australia’s harm minimisation strategy 
focuses on both licit and illicit drugs. Harm 
minimisation includes preventing anticipated harm 
and reducing actual harm.
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HealtHcare profeSSioNalS: 
drug aNd alcoHol 
iNformatioN SerViceS
National Quitline number 13 7848 (cost 
of local call)
australian capital territory
Alcohol and Drug Service (ADIS) 
02 6207 9977
New South wales
NSW Drug and Alcohol Specialist Advisory 
Service (DASAS) 02 9361 8006
(24-hour health professionals telephone 
service) 1800 023 687 (outside Sydney)
Northern territory
Drug and Alcohol Clinical Advisory Service 
(DACAS-NT) 1800 111 092
Queensland
Queensland Drug Information Centre 
07 3636 7098
Therapeutic Advice and Information Service 
1300 138 677
Alcohol and Drug Information Service (ADIS) 
07 3236 2414
(24-hour counselling, information and 
referral) 1800 177 833 (outside Brisbane)
South australia
Alcohol and Drug Information Service (ADIS) 
in SA 1300 13 13 40
tasmania
Drug and Alcohol Clinical Advisory Service 
(DACAS) 1800 630 093
Victoria
The Women’s Alcohol & Drug Service 
(pregnancy care and professional support) 
03 9344 3631
DirectLine (24 hour counselling and referral) 
1800 888 236
western australia
Antenatal Chemical Dependency Clinic 
(ACDC)
Women’s and Children’s Health Service 
08 93401379
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